25Nov 2024
Effect of Beta-blocker Use on Sacubitril/Valsartan Outcomes in HF

Effect of Beta-blocker Use on Sacubitril/Valsartan Outcomes in HF

The study examines the impact of background beta-blocker treatment on the efficacy of sacubitril/valsartan in heart failure with reduced ejection fraction. In the PARADIGM-HF trial, sacubitril/valsartan reduced the risk of heart failure hospitalization and cardiovascular death more in patients not receiving beta-blockers. The benefits were more pronounced in this group, particularly for cardiovascular death and all-cause mortality. Sacubitril/valsartan remained effective regardless of beta-blocker use.

  • #cardiology

Like

Save

Share